Bellevue Group’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,414
| Closed | -$795K | – | 149 |
|
|
2024
Q4 | $795K | Buy |
100,414
+24,000
| +31% | +$190K | 0.02% | 121 |
|
|
2024
Q3 | $636K | Buy |
76,414
+13,654
| +22% | +$114K | 0.01% | 124 |
|
|
2024
Q2 | $399K | Buy |
62,760
+17,373
| +38% | +$110K | 0.01% | 133 |
|
|
2024
Q1 | $275K | Buy |
45,387
+19,917
| +78% | +$121K | ﹤0.01% | 147 |
|
|
2023
Q4 | $155K | Buy |
+25,470
| New | +$155K | ﹤0.01% | 152 |
|
|
2020
Q1 | – | Sell |
-300,000
| Closed | -$1.45M | – | 216 |
|
|
2019
Q4 | $1.45M | Buy |
+300,000
| New | +$1.45M | 0.02% | 144 |
|
|
2019
Q2 | – | Sell |
-100,000
| Closed | -$1.42M | – | 203 |
|
|
2019
Q1 | $1.42M | Buy |
100,000
+5,000
| +5% | +$70.9K | 0.08% | 117 |
|
|
2018
Q4 | $1.29M | Hold |
95,000
| – | – | 0.08% | 106 |
|
|
2018
Q3 | $2.11M | Buy |
95,000
+20,000
| +27% | +$444K | 0.13% | 104 |
|
|
2018
Q2 | $1.23M | Buy |
+75,000
| New | +$1.23M | 0.1% | 113 |
|